Supremes: No Patents on Human DNA

Several years ago, a company discovered the locations of two genes that affect the risk of breast and ovarian cancer, and for this it was awarded numerous patents. These patents gave the company the exclusive right to test for these genes in a given individual, as well as the exclusive right to create “complementary DNA” — a synthetic DNA that omits unnecessary information — based on the genes.

The Supreme Court has held:

A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but [complementary DNA] is patent eligible because it is not naturally occurring.

It also noted:

This case . . . does not involve method claims, patents on new applications of knowledge about the BRCA1 and BRCA2 genes, or the patentability of DNA in which the order of the naturally occurring nucleotides has been altered.

The judges were unanimous in the judgment, though Antonin Scalia filed a concurring opinion.

Most Popular

U.S.

Fire the FBI Chief

American government is supposed to look and sound like George Washington. What it actually looks and sounds like is Henry Hill from Goodfellas: bad suit, hand out, intoning the eternal mantra: “F*** you, pay me.” American government mostly works by interposition, standing between us, the free people at ... Read More
Film & TV

Black Panther’s Circle of Hype

The Marvel Cinematic Universe (MCU) first infantilizes its audience, then banalizes it, and, finally, controls it through marketing. This commercial strategy, geared toward adolescents of all ages, resembles the Democratic party’s political manipulation of black Americans, targeting that audience through its ... Read More